CEVEC Pharma

CEVEC Pharmaceuticals GmbH is a biopharmaceutical company and a leading supplier of high-performance cell technologies for the manufacturing of advanced biotherapeutics from research and development to production scale. The company’s portfolio includes platform technologies for gene therapy viral vectors, viral vaccines, exosomes, and complex recombinant proteins. ELEVECTA® is specifically designed for AAV manufacturing, while CAP® targets adenoviral vectors, lentiviral vectors, oncolytic viruses, and exosomes. CAP®Go is the preferred platform for complex recombinant proteins.